Evidence-based interventions, such as educational strategies, clinical practice guidelines, and audit and feedback, are ...

A first-in-human trial of intravesical BH011, a novel docetaxel formulation, in patients with high risk non-muscle invasive bladder cancer (HR-NMIBC) after BCG failure: Results from a phase 1 study.

In 2006, Jeffrey Pfeffer and Robert I. Sutton noted in their 2006 Harvard Business Review article the emergence of evidence-based medicine and suggested that practice of management too could profit ...

This clinical brief is supported by Boehringer Ingelheim. This clinical brief will explore the prevalence, clinical and economic burden, and management of cardiovascular-renal-metabolic (CRM) ...